Abstract

Tuberculosis morbidity and mortality should be considered unacceptable given the high availability of therapeutic and preventative options. However, vulnerable populations and those with low socioeconomic status face unequal access to diagnosis and treatment.1 Additionally, the increase in poverty and social inequality caused by the current COVID-19 pandemic, combined with the intermittence of health services during the pandemic, has led to a predicted increase in the tuberculosis burden worldwide.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call